MedTrace Logo

Latin American Pulmonary Hypertension Registry

NCT02570737 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2017-01-24

No results posted yet for this study

Summary

The RELAHP registry is a Latin-American multinational, multicenter, prospective observational registry-type cohort study, which pretends to identify clinical characteristics, clinical course, management and outcome of all forms of pulmonary hypertension (PH).

All consecutively consented patients newly diagnosed with WHO Group I-V PH according to specific hemodynamic criteria on right heart catheterization at the participating centers will be enrolled. Patients will be followed six-monthly for a minimum of five years from the time of enrollment.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

  • Actelion

    collaborator INDUSTRY

  • Bayer

    collaborator INDUSTRY

  • Ferrer Internacional S.A.

    collaborator INDUSTRY

  • Asociacion Latinoamericana de Torax

    lead INDUSTRY

Principal Investigators

  • TOMAS R. PULIDO, M.D. · ASOCIACIÓN LATINOAMERICANA DE TORAX

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-07-31
Completion
2019-04-30

Countries

  • Argentina
  • Brazil
  • Chile
  • Colombia
  • Honduras
  • Mexico
  • Uruguay
  • Venezuela

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02570737 on ClinicalTrials.gov